DOCSLIB.ORG

Psychedelic Warfa Exploring the Potenti of Psychoactive Weapons

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Psychedelic Warfa Exploring the Potenti of Psychoactive Weapons & & L 9 Psychedelic Warfa Exploring the Potenti :: - .,. of Psychoactive Weapons Interview with James Ketchum James Ketchum, M.D., is a retired Army colonel, a board-certified psychiatrist, and an assistant clinical professor of psychiatry at UCLA. He received his MD. from Weill Medical College at Cornell University and is the author of the book Chemical Warfare Secrets Almost Forgotten. During the 1960s, Ketchum was a research director for the Army's Chemical Center at Edgewood Arsenal in Maryland, where thousands of U.S. soldiers served as volunteers for the secret testing of psychedelic and deliriant drugs as incapacitating agents. The goal was to develop nonlethal military weapons, which could be used to temporarily knock people out without necessarily hurting them. I found Ketchum's book, Chemical Warfare Secrets Almost Forgotten, to be absolutely fascinating and difficult to put down. It's a treasure chest of rare information, compiled from a massive amount of research of which I was largely unaware. The book is filled with many interesting personal photographs and humorous anecdotes, and it is compulsively readable. Most important, it fills a vital historical gap in the archives of 157 158 Psychedelic Warfare? Exploring the Potential of Psychoactive Weapons psychedelic drug research. From 1955 to 1975 several thousand U.S. editing of the soldiers served as volunteer test subjects for psychedelic drugs (such festival in NE as LSD and strong cannabis derivatives) and deliriant drugs (such as BZ across some and other belladonnoid compounds). The soldiers were administered a battery of physical and cognitive performance tests to see how well they could perform under the drugs' influence. I spoke witl: While reading Ketchum's book I was struck by the strange historical very graciou irony that some of the very drugs that were associated in the 1960s with about his res the counterculture's antiwar movement in America were at the very chemical wa same time being researched as secret military weapons. ons, the fun: While the thought of government-funded experiments into tial of psych. chemical-warfare agents may give you the chills, Ketchum maintains How did yo that his research was motivated by the desire to save human lives and develop more humane, nonlethal weapons. Part of his motivation for JIM: When writing his book was to clear up the misconceptions that many people in stated I war, the media have about the Army's all-volunteer research program, often humanity." . confused with the CIA's notorious and nefarious MK-ULTRA mind- Then Ishift control program, which sometimes even administered LSD to ordinary, psychology, c unwitting U.S. citizens. try when I i Ketchum is a difficult man to pigeonhole as he has always been training in : somewhat of a maverick. In 1966 he was granted two years off from entered the _ his research at Edgewood Arsenal to become a postdoc in neuropsy- near the er., chology with Karl Pribram at Stanford University. While in California he warfare goe' spent time documenting on film the psychedelic subculture in the Bay When you Area and volunteered time as a physician at the Haight Ashbury Free reaction w! Clinic in San Francisco. secret rese. Ketchum also supports research into the potential therapeutic benefits of cannabis and psychedelics; he served for several years as a JIM: The in- member of the National Organization for the Reform of Marijuana Laws school, and (NORML) and is still active in MAPS. Arsenal prc: Ketchum's book contains a foreword by the legendary psychedelic on incapac.: chemist Alexander Shulgin. Popular cyberculture commentator Ken agents. No Goffman (a.k.a. R. U. Sirius, founder of Mondo 2000) helped with the disturbing? r u • An Interview with James Ketchum 159 S?-: U.S. editing of the book. In 2007, Ketchum even lectured at the Burning Man :_::0 .such festival in Nevada, so he's demonstrated a rare ability to communicate _:- :::5 BZ across some pretty varied subcultures. - 0:2red a -------------@------------- .'.e they I spoke with James Ketchum on September 8, 2008. I found Jim to be • - 3::)rical very gracious, and he appears to have a lot of integrity when he talks :::5 with about his research. We discussed his studies at Edgewood Arsenal, why : :-e very chemical warfare agents may be more humane than traditional weap- ons, the future of chemical warfare, and the possible therapeutic poten- e-:5 into tial of psychedelics. -? -:ains How did you become interested in psychiatry? ·25 and ,;,::)~for JIM: When I was eight years old I wrote a composition in class that : e: ole ir. stated I wanted to be a scientist when I grew up and "help struggling often humanity." So when I entered college I started as a premed student. "':"'inc- Then I shifted briefly to a philosophy major. I left it to major in clinical psychology, and finally reverted to premed. I focused my eye on psychia- try when I got through all this switching around. I got the necessary "';" S ceen training in medicine at Cornell University's medical school, but then entered the Army for my internship and residency training. It was only - e _-Ousy- near the end of my residency that the story starts, as far as chemical :"·:-:--iahe warfare goes. -:-e Bay When you graduated from medical school, what was your initial ': .r. Free reaction when you were first approached by the military to do secret research into incapacitating agents? JIM: The invitation came more than four years after completing medical _?-? c.aW5 school, and was actually somewhat of a happenstance. The Edgewood Arsenal program of research into chemical weapons had started to focus ~o. :ledelic on incapacitating agents-which is to say nonlethality, or low-lethality r:?:::- Ker agents. No psychiatrist had been assigned to the medical labs, and a c: .',:" the disturbing psychiatric reaction had occurred in one of their studies. My 160 Psychedelic Warfare? Exploring the Potential of Psychoactive Weapons mentor at Walter Reed, Dr. David Rioch, called me in and said a psy- Meanwl: chiatrist was needed at Edgewood Arsenal, and would I be interested in type, which such an assignment? I grabbed at it, because it seemed challenging and qualitatively really interesting. centuries. Sc the tic to red What were some of the chemical agents that you studied at BZ diffe Edgewood, and what did you learn about them? and up to t\'. JIM: Before my arrival LSD was the only agent that had been studied in by injection some detail. My predecessor, Dr. Van Sim, initiated and supervised most duce an inca of the human research prior to 1961. But a new and different agent was followed by provided to the Army a few months before I arrived. Over time it was The oth. referred to by a number of names, but finally was called simply BZ. I even better. spent the better part of three years studying it intensively and eventu- with very Ii: ally writing up a detailed summary. I also did, however, some additional cal effects v work with LSD, and with a variant of THC-tetrahydrocannabinol- that some si: provided by Harry Pars, a chemist at A.D. Little, with some technical Thus we we: guidance by Dr. Alexander Shulgin, primarily known, then and now, structural r: for his creative synthesis of psychedelic drugs. potent, mor: It was evident that this variant of THC had several times the while the A: potency of THC found in marijuana, so there was speculation that it and put ther might be powerful enough to be useful as an incapacitating agent. It unpopular '.' certainly was predicted to be safe, much like the marijuana to which it weapons of; was related, but it lacked sufficient intoxicating effects in the dose range Why do yc we studied. It was obvious that it wouldn't be a practical agent, so after humane the a brief trial with the volunteer subjects, I turned my attention almost what inspir entirely to BZ, whose effects I thereafter studied in detail with the help Almost For, of more than three hundred highly cooperative enlisted soldiers. Convinced of its effectiveness and safety, BZ was actually adopted JIM: It seer: by higher Army echelons as the first, and only, standard incapacitating duce nonletl agent. It was produced in quantity and loaded into volleyball-size born- conventiona blets for delivery as an aerosol from overhead aircraft. I had very little your mind-s to do with this phase, nor was I particularly interested in the dispersal 1960s the ic aspects. ally accepte( r- i I [. :,.Veapons An Interview with James Ketchum 161 c.:-. -=- said a psy- Meanwhile, we continued to study additional compounds of similar ~~.nrerested in type, which is to say the belladonnoid category, since their effects were :~.:enging and qualitatively very much like atropine, a drug approved for use for many centuries. Some people may be familiar with atropine, used as a preanes- thetic to reduce salivation. II.' studied at BZ differs from atropine in that it is about twenty times as potent and up to twenty times longer lasting than atropine. The dose required :-~::1studied in by injection or inhalation is only about half a milligram, enough to pro- .-~-~;~------ c::rvised most duce an incapacitating delirium lasting forty-eight to ninety-six hours, , , '0". ' (:;to' - ::::::--.L agent was followed by full recovery. .1- -;:: = rime it was The other compounds that came under scrutiny after BZ were often .: '~mply BZ. I even better. Some acted relatively more on the central nervous system, ::-- and eventu- with very little effect on heart rate or blood pressure. Such physiologi- ,=~.C additional cal effects were more characteristic of atropine and BZ.
Load more

Recommended publications
  • Substance Abuse and Dependence
    9 Substance Abuse and Dependence CHAPTER CHAPTER OUTLINE CLASSIFICATION OF SUBSTANCE-RELATED THEORETICAL PERSPECTIVES 310–316 Residential Approaches DISORDERS 291–296 Biological Perspectives Psychodynamic Approaches Substance Abuse and Dependence Learning Perspectives Behavioral Approaches Addiction and Other Forms of Compulsive Cognitive Perspectives Relapse-Prevention Training Behavior Psychodynamic Perspectives SUMMING UP 325–326 Racial and Ethnic Differences in Substance Sociocultural Perspectives Use Disorders TREATMENT OF SUBSTANCE ABUSE Pathways to Drug Dependence AND DEPENDENCE 316–325 DRUGS OF ABUSE 296–310 Biological Approaches Depressants Culturally Sensitive Treatment Stimulants of Alcoholism Hallucinogens Nonprofessional Support Groups TRUTH or FICTION T❑ F❑ Heroin accounts for more deaths “Nothing and Nobody Comes Before than any other drug. (p. 291) T❑ F❑ You cannot be psychologically My Coke” dependent on a drug without also being She had just caught me with cocaine again after I had managed to convince her that physically dependent on it. (p. 295) I hadn’t used in over a month. Of course I had been tooting (snorting) almost every T❑ F❑ More teenagers and young adults die day, but I had managed to cover my tracks a little better than usual. So she said to from alcohol-related motor vehicle accidents me that I was going to have to make a choice—either cocaine or her. Before she than from any other cause. (p. 297) finished the sentence, I knew what was coming, so I told her to think carefully about what she was going to say. It was clear to me that there wasn’t a choice. I love my T❑ F❑ It is safe to let someone who has wife, but I’m not going to choose anything over cocaine.
    [Show full text]
  • Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test
    DOCUMENT RESUME ED 034 696 SE 007 743 AUTROP Meyer, Roger E. , Fd. TITLE Adverse Reactions to Hallucinogenic Drugs. 1rNSTTTUTTON National Test. of Mental Health (DHEW), Bethesda, Md. PUB DATP Sep 67 NOTE 118p.; Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967 AVATLABLE FROM Superintendent of Documents, Government Printing Office, Washington, D. C. 20402 ($1.25). FDPS PRICE FDPS Price MFc0.50 HC Not Available from EDRS. DESCPTPTOPS Conference Reports, *Drug Abuse, Health Education, *Lysergic Acid Diethylamide, *Medical Research, *Mental Health IDENTIFIEPS Hallucinogenic Drugs ABSTPACT This reports a conference of psychologists, psychiatrists, geneticists and others concerned with the biological and psychological effects of lysergic acid diethylamide and other hallucinogenic drugs. Clinical data are presented on adverse drug reactions. The difficulty of determining the causes of adverse reactions is discussed, as are different methods of therapy. Data are also presented on the psychological and physiolcgical effects of L.S.D. given as a treatment under controlled medical conditions. Possible genetic effects of L.S.D. and other drugs are discussed on the basis of data from laboratory animals and humans. Also discussed are needs for futher research. The necessity to aviod scare techniques in disseminating information about drugs is emphasized. An aprentlix includes seven background papers reprinted from professional journals, and a bibliography of current articles on the possible genetic effects of drugs. (EB) National Clearinghouse for Mental Health Information VA-w. Alb alb !bAm I.S. MOMS Of NAM MON tMAN IONE Of NMI 105 NUNN NU IN WINES UAWAS RCM NIN 01 NUN N ONMININI 01011110 0.
    [Show full text]
  • PSYCHEDELIC DRUGS (P.L) 1. Terminology “Hallucinogens
    PSYCHEDELIC DRUGS (p.l) 1. Terminology “hallucinogens” – induce hallucinations, although sensory distortions are more common “psychotomimetics” – to minic psychotic states, although truly most drugs in this class do not do so “phantasticums”or “psychedelics” – alter sensory perception (Julien uses “psychedelics”) alterations in perception, cognition, and mood, in presence of otherwise clear ability to sense” may increase sensory awareness, increase clarity, decrease control over what is sensed/experienced “self-A” may feel a passive observer of what “self-B” is experiencing often accompanied by a sense of profound meaningfulness, of divine or cosmic importance (limbic system?) these drugs can be classified by what NT they mimic: anti-ACh, agonists for NE, 5HT, or glutamate (See p. 332, Table 12.l in Julien, 9th Ed.) 2. The Anti-ACh Psychedelics e.g. scopolamine (classified as an ACh blocker) high affinity, no efficacy plant product: Belladonna or “deadly nightshade” (Atropa belladonna) Datura stramonium (jimson weed, stinkweed) Mandragora officinarum (mandrake plant) pupillary dilation (2nd to atropine) PSYCHEDELIC DRUGS (p.2) 2. Anti-ACh Psychedelics (cont.) pharmacological effects: e.g. scopolamine (Donnatal) clinically used to tx motion sickness, relax smooth muscles (gastric cramping), mild sedation/anesthetic effect PNS effects --- dry mouth relaxation of smooth muscles decreased sweating increased body temperature blurred vision dry skin pupillary dilation tachycardia, increased BP CNS effects --- drowsiness, mild euphoria profound amnesia fatigue decreased attention, focus delirium, mental confusion decreased REM sleep no increase in sensory awareness as dose increases --- restlessness, excitement, hallucinations, euphoria, disorientation at toxic dose levels --- “psychotic delirium”, confusion, stupor, coma, respiratory depression so drug is really an intoxicant, amnestic, and deliriant 3.
    [Show full text]
  • References to Argentina
    References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The Americas (pages 12 to 14 WDR 13) In the Americas, a high prevalence of most illicit drugs, essentially driven by estimates in North America, was observed, with the prevalence of cannabis (7.9 per cent) and cocaine (1.3 per cent) being particularly high in the region. South America, Central America and the Caribbean The annual prevalence of cocaine use in South America (1.3 per cent of the adult population) is comparable to levels in North America, while it remains much higher than the global average in Central America (0.6 per cent) and the Caribbean (0.7 per cent). Cocaine use has increased significantly in Brazil, Costa Rica and, to lesser extent, Peru while no change in its use was reported in Argentina. The use of cannabis in South America is higher (5.7 per cent) than the global average, but lower in Central America and Caribbean (2.6 and 2.8 per cent respectively). In South America and Central America the use of opioids (0.3 and 0.2 per cent, respectively) and Ecstasy (0.1 per cent each) also remain well below the global average. While opiates use remains low, countries such as Colombia report that heroin use is becoming increasingly common among certain age groups and socio-economic classes.30 Part 2 NEW PSYCHOACTIVE SUBSTANCES C. THE RECENT EMERGENCE AND SPREAD OF NEW PSYCHOACTIVE SUBSTANCES (page 67 WDR 13) Spread at the global level Number of countries reporting the emergence of new psychoactive substances Pursuant to Commission on Narcotic Drugs resolution 55/1, entitled “Promoting international cooperation in responding to the challenges posed by new psychoactive substances”, in 2012 UNODC sent a questionnaire on NPS to all Member States, to which 80 countries and territories replied.
    [Show full text]
  • The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming Within a Large Database of Psychoactive Substance Reports
    ORIGINAL RESEARCH published: 22 January 2018 doi: 10.3389/fnins.2018.00007 The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports Camila Sanz 1, Federico Zamberlan 1, Earth Erowid 2, Fire Erowid 2 and Enzo Tagliazucchi 1,3* 1 Departamento de Física, Universidad de Buenos Aires, Buenos Aires, Argentina, 2 Erowid Center, Grass Valley, CA, United States, 3 Brain and Spine Institute, Paris, France Ever since the modern rediscovery of psychedelic substances by Western society, Edited by: several authors have independently proposed that their effects bear a high resemblance Rick Strassman, to the dreams and dreamlike experiences occurring naturally during the sleep-wake University of New Mexico School of cycle. Recent studies in humans have provided neurophysiological evidence supporting Medicine, United States this hypothesis. However, a rigorous comparative analysis of the phenomenology (“what Reviewed by: Matthias E. Liechti, it feels like” to experience these states) is currently lacking. We investigated the semantic University Hospital Basel, Switzerland similarity between a large number of subjective reports of psychoactive substances and Michael Kometer, University of Zurich, Switzerland reports of high/low lucidity dreams, and found that the highest-ranking substance in *Correspondence: terms of the similarity to high lucidity dreams was the serotonergic psychedelic lysergic Enzo Tagliazucchi acid diethylamide (LSD), whereas the highest-ranking in terms of the similarity to dreams [email protected] of low lucidity were plants of the Datura genus, rich in deliriant tropane alkaloids. Specialty section: Conversely, sedatives, stimulants, antipsychotics, and antidepressants comprised most This article was submitted to of the lowest-ranking substances.
    [Show full text]
  • Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models
    ZEBRAFISH Volume 13, Number 5, 2016 Review Articles ª Mary Ann Liebert, Inc. DOI: 10.1089/zeb.2016.1251 Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models Evan J. Kyzar1 and Allan V. Kalueff2–6 Abstract After decades of sociopolitical obstacles, the field of psychiatry is experiencing a revived interest in the use of hallucinogenic agents to treat brain disorders. Along with the use of ketamine for depression, recent pilot studies have highlighted the efficacy of classic serotonergic hallucinogens, such as lysergic acid diethylamide and psilocybin, in treating addiction, post-traumatic stress disorder, and anxiety. However, many basic phar- macological and toxicological questions remain unanswered with regard to these compounds. In this study, we discuss psychedelic medicine as well as the behavioral and toxicological effects of hallucinogenic drugs in zebrafish. We emphasize this aquatic organism as a model ideally suited to assess both the potential toxic and therapeutic effects of major known classes of hallucinogenic compounds. In addition, novel drugs with hal- lucinogenic properties can be efficiently screened using zebrafish models. Well-designed preclinical studies utilizing zebrafish can contribute to the reemerging treatment paradigm of psychedelic medicine, leading to new avenues of clinical exploration for psychiatric disorders. Introduction requiring the use of both traditional (rodent) and novel model species.6 In this study, we briefly review the history of psy- allucinogenic drugs have been used by humans for chedelic medicine and the pharmacology of these drugs and centuries, exerting potent effects on thought, cognition, H discuss the effects of hallucinogenic drugs on larval and adult and behavior with little propensity for habit formation and zebrafish (Danio rerio).
    [Show full text]
  • Reversible Worsening of Psychosis Due to Benzydamine in a Schizoaffective Young Girl Who Is Already Under Treatment with Antipsychotics
    Olgu Sunumlar› / Case Reports Reversible Worsening of Psychosis Due to Benzydamine in a Schizoaffective Young Girl Who is Already under Treatment with Antipsychotics Mehmet Kerem Doksat ÖZET: ABSTRACT: Antipsikotiklerle tedavi alt›nda olan flizoaffek- Reversible worsening of psychosis due to tif bir genç k›zda benzidamin kullan›lmas›na benzydamine in a schizoaffective young girl ba¤l› olarak geliflen reversibl psikoz kötülefl- who is already under treatment with mesi antipsychotics Ülkemizde Tantum, Tanflex, Benzidan gibi isimlerle sat›lan Benzydamine, available as the hydrochloride form, is an benzidamid hidroklorid, antienflamatuar ve analjezik ola- anti-inflammatory drug providing both rapid and rak s›kl›kla kullan›lan bir ilâçt›r. 500 ilâ 3000 mg gibi oral extended pain relief in many painful inflammatory dozlarda “deliran” (kafa bulucu) etkisi görülür; yarat›c›l›¤› conditions. In oral dosages of 500 mg to 3000 mg it is a artt›r›c› hallüsinozise (ego-distonik hallüsinasyonlara) ve “deliriant” and CNS stimulant, popular in Poland and Brazil. öforiye yol açt›¤› için, Polonya ve Brezilya’da s›kl›kla kulla- In Brazil it is so popular that many people use it for n›lmaktad›r. Yüksek dozlarda panoya, a¤›z kurulu¤u ve recreational purposes. A person in a “benzydamine trip” konvülsiyonlar görülebilir ve 2000–3000 mg dozlar›nda may experience a feeling of well-being, euphoria and in merkezî sinir sistemini uyar›c› etkisi belirginleflir. Bu “trip- higher doses hallucinations, paranoia, dry mouth and ler” bilerek veya kazaen al›nan yüksek dozlardan sonra or- convulsions may also be experienced. In dosages of 750 taya ç›k›p, ilâç kesilince 2 ilâ 3 günde kendili¤inden düzelir.
    [Show full text]
  • Hallucinogens As Treatment? Preliminary Data with Ketamine
    Hallucinogens as Treatment? Preliminary Data with Ketamine Elias Dakwar, MD Columbia University College of Physicians and Surgeons 19 October, 2017 Disclosures Elias Dakwar has received funding from NIDA and NIAAA. He has no conflicts of interest to report. Overview How might hallucinogens work as treatment? Why might ketamine work as a treatment? By any other name Deliriant Entheogen Hallucinogen Imaginant Oneirogen Phanarothyme Phantasticant Psychedelic Psychotomimetic A diverse group Indoles - d-lysergic-acid (LSD), dimethyltryptamine (DMT), harmaline, ibogaine, psilocybin, Dissociative Anesthetics - ketamine, PCP Phenethylamines -mescaline, 2-CB, DOM, MDA, MDMA Others - nitrous oxide, salvia divinorum, THC, fly agaric mushroom Effects Produce in a time-limited manner non-ordinary experiences comparable to: trance psychosis ecstasy dreaming mystical experience Ancient Uses Ritual Divination Initiation Pleasure Healing Witchcraft Protection/fortification Modern Uses Classical hallucinogens were investigated in the 1950s through the early ’70s in various settings. psychiatric treatment quality of life improvement investigations of consciousness criminal justice warfare “Psychedelic” and “Psycholytic” treatment models Concern over recreational use obscured promising clinical data and clinical research was largely aborted due to criminalization in 1973. But has recently resumed via private foundation funding Set and Setting A valuable heuristic for optimizing benefits, minimizing risks Set: the recipient’s expectations, past experiences,
    [Show full text]
  • Natural Psychodysleptic Compounds: Sources and Pharmacology
    Online - 2455-3891 Vol 9, Issue 5, 2016 Print - 0974-2441 Review Article NATURAL PSYCHODYSLEPTIC COMPOUNDS: SOURCES AND PHARMACOLOGY SISIRA PADAVALA, EZHILARASAN D* Department of Pharmacology, Saveetha Dental College and Hospital, Chennai - 600 077, Tamil Nadu, India. Email: [email protected] Received: 08 June 2016, Revised and Accepted: 23 June 2016 ABSTRACT Compounds in some plants have remarkable effects on the central nervous system. Plants containing those compounds are mind altering or psychoactive in nature. These are consumed in the form of simple or complex preparations to affect the mind or alter the state of consciousness. Psychoactivity may include sedative, stimulant, euphoric, deliriant, and hallucinogenic effects. Several hundred psychoactive plants are known. Some important examples of psychoactive plants include Datura, Salvia, and Cannabis. Psychoactive plants have been used ritually, medicinally, and recreationally for thousands of years. Hence, the sociocultural and economic significance of psychoactive plants is enormous. Keywords: Cannabis, Datura, Psychoactive plants, Euphoria, Hallucinogen. © 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2016.v9i5.13345 INTRODUCTION negative thoughts about one’s own self and also through, a range of confusing anomalous experiences [1]. The phytochemical constituents Hallucinogenic plants have been used by man for thousands of years. obtained from Cannabis show diverse biological effects in almost all Many species of hallucinogenic (psychodysleptic) plants are used organ systems especially cardiac, respiratory and immune system. by humans worldwide to achieve states of mind distortions; among Cannabinoid receptors (CB1 and CB2), THC are responsible for all the those, a few have been used for therapeutic purposes such as Cannabis effects of cannabis.
    [Show full text]
  • Psychoactive Natural Products: Overview of Recent Developments
    12 Ann Ist Super Sanità 2014 | Vol. 50, No. 1: 12-27 DOI: 10.4415/ANN_14_01_04 Psychoactive natural products: overview of recent developments István Ujváry REVIEWS iKem BT, Budapest, Hungary AND Abstract Natural psychoactive substances have fascinated the curious mind of shamans, artists, Key words ARTICLES scholars and laymen since antiquity. During the twentieth century, the chemical com- • ethnopharmacology position of the most important psychoactive drugs, that is opium, cannabis, coca and • mode of action “magic mushrooms”, has been fully elucidated. The mode of action of the principal in- • natural products gredients has also been deciphered at the molecular level. In the past two decades, the • psychopharmacology RIGINAL use of herbal drugs, such as kava, kratom and Salvia divinorum, began to spread beyond • toxicology O their traditional geographical and cultural boundaries. The aim of the present paper is to briefly summarize recent findings on the psychopharmacology of the most prominent psychoactive natural products. Current knowledge on a few lesser-known drugs, includ- ing bufotenine, glaucine, kava, betel, pituri, lettuce opium and kanna is also reviewed. In addition, selected cases of alleged natural (or semi-natural) products are also mentioned. O, mickle is the powerful grace that lies In herbs, plants, stones, and their true qualities William Shakespeare (Romeo and Juliet) INTRODUCTION Historical background of psychoactive natural During the past 200 years, there has been major pro- products research gress in our understanding of the composition and ef- The biochemical machinery of an organism generates fects of many psychoactive natural products, particular- many structurally related chemicals (Nature’s “combinato- ly those that have therapeutic uses.
    [Show full text]
  • Dextromethorphan
    Dextromethorphan sc-278927 Material Safety Data Sheet Hazard Alert Code EXTREME HIGH MODERATE LOW Key: Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME Dextromethorphan STATEMENT OF HAZARDOUS NATURE CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO OSHA 29 CFR 1910.1200. NFPA FLAMMABILITY1 HEALTH2 HAZARD INSTABILITY0 SUPPLIER Santa Cruz Biotechnology, Inc. 2145 Delaware Avenue Santa Cruz, California 95060 800.457.3801 or 831.457.3800 EMERGENCY ChemWatch Within the US & Canada: 877-715-9305 Outside the US & Canada: +800 2436 2255 (1-800-CHEMCALL) or call +613 9573 3112 SYNONYMS C18-H25-N-O, (+)-3-methoxy-9a-methylmorphinan, "morphinan, 3-methoxy-17-methyl-, (9-alpha, 13-alpha, 14-alpha)-", dextromethorfan, d-methorphan, delta-methorphan, "9-alpha, 13-alpha, 14-alpha-morphinan, 3-methoxy-17-methyl-", Romilar, BA-2666, "kappa-opioid agonist" Section 2 - HAZARDS IDENTIFICATION CHEMWATCH HAZARD RATINGS Min Max Flammability 1 Toxicity 2 Min/Nil=0 Body Contact 0 Low=1 Reactivity 1 Moderate=2 High=3 Chronic 2 Extreme=4 1 of 11 CANADIAN WHMIS SYMBOLS EMERGENCY OVERVIEW RISK Harmful if swallowed. Possible risk of irreversible effects. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. POTENTIAL HEALTH EFFECTS ACUTE HEALTH EFFECTS SWALLOWED ■ Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual. ■ Drowsiness, dizziness, excitation, mental confusion and gastro-intestinal disturbances have been described following dextromethorphan. administration. ■ NMDA antagonists have been used as neuroprotective agents counteracting the effects of overactivation of the receptor; however such antagonists may also be harmful, at high doses, as the neuron also needs calcium for normal function.
    [Show full text]
  • Understanding Complex Dynamics of Behavioral, Neurochemical and Transcriptomic Changes Induced by Prolonged Chronic Unpredictable Stress in Zebrafsh Konstantin A
    www.nature.com/scientificreports OPEN Understanding complex dynamics of behavioral, neurochemical and transcriptomic changes induced by prolonged chronic unpredictable stress in zebrafsh Konstantin A. Demin1,2*, Anton M. Lakstygal1, Nataliya A. Krotova1,2, Alexey Masharsky3, Natsuki Tagawa4, Maria V. Chernysh1, Nikita P. Ilyin1, Alexander S. Taranov1, David S. Galstyan1,5, Ksenia A. Derzhavina2, Nataliia A. Levchenko1, Tatiana O. Kolesnikova1, Mikael S. Mor1, Marina L. Vasyutina2, Evgeniya V. Efmova1, Nataliia Katolikova1,7, Andrey D. Prjibelski8, Raul R. Gainetdinov1, Murilo S. de Abreu9, Tamara G. Amstislavskaya10,11, Tatyana Strekalova12,13,14 & Allan V. Kaluef6,15,16* Stress-related neuropsychiatric disorders are widespread, debilitating and often treatment-resistant illnesses that represent an urgent unmet biomedical problem. Animal models of these disorders are widely used to study stress pathogenesis. A more recent and historically less utilized model organism, the zebrafsh (Danio rerio), is a valuable tool in stress neuroscience research. Utilizing the 5-week chronic unpredictable stress (CUS) model, here we examined brain transcriptomic profles and complex dynamic behavioral stress responses, as well as neurochemical alterations in adult zebrafsh and their correction by chronic antidepressant, fuoxetine, treatment. Overall, CUS induced complex neurochemical and behavioral alterations in zebrafsh, including stable anxiety-like behaviors and serotonin metabolism defcits. Chronic fuoxetine (0.1 mg/L for 11 days) rescued most of
    [Show full text]